ENROFLOXACIN- enrofloxacin powder
AX Pharmaceutical Corp
----------
Enrofloxacin
Enrofloxacin


ENROFLOXACIN
enrofloxacin powder |
| Product Information |
| Product Type | | Item Code (Source) | NDC: 73377-117 |
| Route of Administration | NOT APPLICABLE |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ENROFLOXACIN (UNII: 3DX3XEK1BN) (ENROFLOXACIN - UNII:3DX3XEK1BN) | ENROFLOXACIN | 1 g in 1 g |
|
| Product Characteristics |
| Color | yellow | Score | |
| Shape | | Size | |
| Flavor | | Imprint Code | |
| Contains | |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 73377-117-01 | 500 g in 1 JAR | | |
| 2 | NDC: 73377-117-02 | 5000 g in 1 JAR | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| bulk ingredient for animal drug compounding | | 03/10/2021 | 01/19/2026 |
|
| Labeler - AX Pharmaceutical Corp
(204011316)
|
| Establishment |
| Name | Address | ID/FEI | Business Operations |
| AX Pharmaceutical Corp | | 204011316 | repack, relabel |
© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.